Dizal Pharmaceuticals
Clinical trials sponsored by Dizal Pharmaceuticals, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug combo offers hope for tough lung cancer Results expected Dec 2026 (estimated)
- Can a new pill boost chemotherapy against Hard-to-Treat lung cancer? Results expected Jun 2027 (estimated)
- New pill could help ITP patients who failed standard treatments Results expected Jul 2027 (estimated)
- New hope for blood cancer patients: experimental drug DZD8586 enters phase 2 trial Results expected Sep 2027 (estimated)
- New pill shows promise in early lung cancer trial Results expected Sep 2027 (estimated)